NewswireToday - /newswire/ -
Rennes, Ille-et-Vilaine, France, 2009/03/12 - Biotrial, will be showcasing at two major Pharmaceutical and Biotech Industry events in March 2009 – in Milan, Italy, at the Milano Convention Center and American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Washington DC - Biotrial.com.
Biotrial, who has developed an extensive experience with Biotech companies, will be participating in the BIO-Europe Spring 2009 conference. This event, the springtime counterpart of BIO-Europe, brings together leading international pharmaceutical and biotech companies from March 16–18, 2009 in Milan, Italy, at the Milano Convention Center (MIC).
As a leading Contract Research Organization, Biotrial offers biotech companies a global solution tailored to their product development, encompassing early non clinical phase (including toxicology studies), Phase I, Phase II and on. People attending this event are able to set direct meetings with the Biotrial team through the partneringONE system which allows attendees to have direct access to the Biotrial team agenda and make appointments. Didier Chassard, MD, Associate Medical and Scientific Director at Biotrial will present.
Later in the month another Biotrial team will be exhibiting the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Washington DC, March 18-21, 2009.
Since 1989, Biotrial offers a wide range of services in the clinical development arena from Phase I, proof of concept, QT studies to central ECG laboratory, biostatistics, report writing, and so forth.
“Alain Patat, Biotrial VP of Medical and Scientific Affairs, and I are excited to attend this event again this year,” said Jean-Marc Gandon, Biotrial CEO. “It is an essential conference for people involved with pharmacology worldwide. For us it is a great opportunity to listen to talks given by key professionals and specialists, to visit with our clients in an informal setting, and to explore possible collaborations with other sponsors.”
Biotrial will be exhibiting at ASCPT’s Booth #100.
Founded in 1989 by Jean-Marc Gandon, PharmD, (President & CEO), Biotrial (biotrial.com) is an independent and privately owned CRO.
With 150 beds and a staff of 250 in several subsidiaries in France and the UK, Biotrial runs over 80 studies per year, either in their own clinics in Paris and Rennes, or in cooperation with hospital specialists and general practitioners.
With a large range of services from Phase I studies, Clinical Trial Management Phase II-IV, Oncology, Data Management, Biostatistics, Central Labs (ECG, MRI), Medical Writing, Non-Clinical Pharmacology, QA & advice in Regulatory Affairs, Biotrial can manage every step of your development process.